Why investors are regretting giving Gland Pharma IPO a miss
Gland Pharma, promoted by China’s Fosun, has extended its gains, is up 40 per cent since its listing. Retail and high-networth individuals (HNIs) would be ruing giving China’s Fosun-promoted Gland … Read More
